ERBB2 and chromosome 17 centromere studies of ovarian cancer by fluorescence in situ hybridization

Genes Chromosomes and Cancer

Volumn 16, Issue 2, 1996, Pages 130-137

  Young, S Robert ^a   Liu, Wei Hua ^a   Brock, Jo Ann ^a   Smith, S Terrell ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CENTROMERE; CHROMOSOME 17; CONTROLLED STUDY; DISOMY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MONOSOMY; ONCOGENE NEU; OVARY CANCER; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, SOUTHERN; CENTROMERE; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENES, ERBB-2; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS;

EID: 0029680069     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199606)16:2<130::AID-GCC7>3.0.CO;2-0     Document Type: Article

References (33)

1. Ali IU, Aambell G, Lidereau R, Callahan R (1988) Amplification of c-erb B2 and aggressive human breast tumors? Science 240:1795-1798.
2. Atkins NB, Pickthall VJ (1977) Chromosomes 1 in 14 ovarian cancers. Heterochromatin variants and structural changes. Hum Genet 38:25-33.
3. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clark-Pearson DL, Marks P, McKenzie S, Yin S, Bast RC Jr (1990) Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50:4087-4091.
4. Busmanis I, Felippa F, Jones A, McGrath KM, Reed R, Collins J, Russell I, Begley CG (1994) Analysis of c-erb B-2 expression using a panel of 6 commercially available antibodies. Pathology 26:261-267.
5. Chattopadhyay S, Marinduque B, Gilbert F (1992) Ovarian cancer: Protocol for the preparation of banded metaphases from tumor tissue. Cancer Genet Cytogenet 59:210-212.
6. Droegemueller W (1994) Screening for ovarian carcinoma: Hopeful and wishful thinking. Am J Obstet Gynecol 170:1095-1098.
7. Gallion HH, Powell DE, Smith LW, Morrow JK, Martin AW, Van Nagell JR, Donaldson ES (1990) Chromosome abnormalities in human epithelial ovarian malignancies. Gynecol Oncol 38:473-477.
8. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King M-C (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684-1689.
9. Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS, Podratz KC (1992) HER-2/neu expression: A major prognostic factor in endometrial cancer. Gynecol Oncol 47:179-185.
10. Isobe M, Emanuel BS, Givol D, Oren M, Croce CM (1986) Localization of the gene for human p53 tumor antigen to band 17p13. Nature 320:84-85.
11. Jacobs I, Bast RC Jr (1989) The CA125 tumor-associated antigen: A review of the literature. Hum Reprod 4:1-12.
12. Kallioniemi O-P, Kallioniemi A, Kurisu W, Thor A, Chen L-C, Smith HS, Walkman FM, Pinkel D, Gray JW (1992) ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 89:5321-5325.
13. McBride OW, Merry D, Givol D (1986) The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci USA 83:130-134.
14. McGill JR, Beitzel BF, Nielsen JL, Walsh JT, Drabek SM, Meador RJ, Von Hoff DD (1993) Double minutes are frequently found in ovarian carcinomas. Cancer Genet Cytogenet 71:125-131.
15. Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koener F, Cirrincione CT, Budman DR, Wood WC, Barcos M, Henderson JC (1994) C-erb B-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. New Engl J Med 330:1260-1366.
16. Ozols RF, Hamilton TC, Hoskins WJ, Bast RC Jr, Young RC (1991) Summary of symposium: Biology and therapy of ovarian cancer. Semin Oncol 18:297-306.
17. Pierce LJ, Merino MJ, D'Angela T, Barker EA, Gilbert L, Cowan KH, Steinberg SM, Glatstein E (1994) c-erb B-2: A predictor for recurrent disease in early stage breast cancer? Int J Radiat Oncol Biol Phys 23:395-403.
18. Popescu NC, King CR, Kraus MH (1989) Localization of the human erb B-2 gene on normal and rearranged chromosomes 17 to bands q12-21.3. Genomics 4:362-366.
19. Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R, Paterson MC, Slamon DJ (1993) Her-2/neu expression in node-negative breast cancer: Direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res 53:4960-4970.
20. Press MF, Hung G, Godolphin W, Slamon DJ (1994) Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 54:2771-2777.
21. Qazi F, McGuire WP (1995) The treatment of epithelial ovarian cancer. Cancer 45:88-101.
22. Sauter G, Moch H, Moore D, Carroll P, Kerschmann R, Chew K, Mihatsch MJ, Judat F, Waldman F (1993) Heterogeneity of erb B-2 gene amplification in bladder cancer. Cancer Res 53:2199-2203.
23. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: Correlation of relapse and survival with amplification of the Her-2/neu oncogene. Science 235: 177-182.
24. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Kent DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712.
25. Tanaka K, Boice CR, Testa JR (1989) Chromosome aberrations in nine patients with ovarian cancer. Cancer Genet Cytogenet 43: 1-14.
26. Tanner B, Freidberg T, Mitze M, Beck T, Oesch F, Knapstein P-G (1992) C-erb B-2 oncogene expression in breast carcinomas: Analysis by S1 nuclease protection assay and immunohistochemistry in relation to clinical parameters. Gynecol Oncol 47:228-233.
27. Taylor KJW, Schwartz PE (1994) Screening for early ovarian cancer. Radiology 192:1-10.
28. Teneriello MG, Park RC (1995) Early detection of ovarian cancer. Cancer 45:71-87.
29. Tyson FL, Boyer CM, Kaufman R, O'Briant K, Cram G, Crews JR, Soper JT, Daly L, Fowler WC, Haskill JS, Bast RC Jr (1991) Expression and amplification of the HER-2/neu (c-erb B-2) protooncogene in epithelial ovarian tumors and cell lines. Am J Obstet Gynecol 165:640-646.
30. Wake N, Hreshchyshyn MM, Piver SM, Matsui S, Sandberg AA (1980) Specific chromosome change in ovarian cancer. Cancer Genet Cytogenet 2:87-88.
31. Whang-Peng J, Knutsen T, Douglass EC, Chu E, Ozols RF, Hogan WM, Young RC (1984) Cytogenetic studies in ovarian cancer. Cancer Genet Cytogenet 11:91-106.
32. Wingo PA, Tong T, Bolden S (1995) Cancer statistics 1995. Cancer 45:8-30.
33. Zhou D, Battifora H, Yokota J, Yamamoto T, Cline MJ (1987) Association of multiple copies of the c-erb B-2 oncogene with spread of breast cancer. Cancer Res 47:6123-6125.